AI assistant
Sending…
Humacyte, Inc. — Director's Dealing 2021
Aug 27, 2021
33410_dirs_2021-08-27_ba2d61f1-7681-4859-94a3-8940389c4de0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2021-08-26
Reporting Person: Sebelius Kathleen (Director)
More from Humacyte, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 24
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 19
Major Shareholding Notification
2026
Jan 9
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Dec 16
Regulatory Filings
2025
Dec 15
Regulatory Filings
2025
Dec 15